selegiline has been researched along with Migraine Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Argiro, G; Atzei, GP; Bernardi, G; Calabresi, P; Cupini, LM; Silvestrini, M; Stratta, F | 1 |
| Harper, AM; McCulloch, J | 1 |
| Kuritzky, A; Melamed, E; Zoldan, Y | 1 |
1 trial(s) available for selegiline and Migraine Disorders
| Article | Year |
|---|---|
Selegeline, a MAO B inhibitor, is not effective in the prophylaxis of migraine without aura--an open study.
Topics: Adult; Female; Humans; Male; Middle Aged; Migraine Disorders; Selegiline | 1992 |
2 other study(ies) available for selegiline and Migraine Disorders
| Article | Year |
|---|---|
l-deprenyl test in migraine: neuroendocrinological aspects.
Topics: Adult; Female; Growth Hormone; Humans; Migraine Disorders; Neurosecretory Systems; Prolactin; Reference Values; Selegiline | 1993 |
Factors influencing the response of the cerebral circulation to phenylethylamine.
Topics: Animals; Blood-Brain Barrier; Cerebrovascular Circulation; Haplorhini; Migraine Disorders; Monoamine Oxidase Inhibitors; Norepinephrine; Oxygen Consumption; Phenethylamines; Phenoxybenzamine; Pimozide; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Receptors, Dopamine; Selegiline | 1979 |